Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 8, 2016 · 10-Q · 39 days after period end · 0001193125-16-675250
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2013 |
|---|---|---|---|---|
| Net Income | -$43.23M | -$23.11M | -$19.01M | -$15.41M |
| EPS Diluted | -$1.17 | -$0.74 | -$0.78 | -$1.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 8, 2016 · 39 d after period end
